Clinical outcomes of brain tumors
The research group on clinical outcomes in Neuro-Oncology focuses on non-traditional outcome measures in patients with a primary or secondary brain tumor (glioma, meningioma, and brain metastases), particularly health-related quality of life (HRQoL), functioning in daily life, clinical symptoms (e.g. epilepsy, cognitive functioning), and radiological outcomes.
The research group has the aim to improve the outcome of patients in terms of functioning, wellbeing and HRQoL, by:
- Evaluating and developing new measurement tools to better assess the patient’s symptoms, functioning and wellbeing;
- Evaluating the impact of different cancer treatments in large clinical trials on clinical outcomes;
- Reducing the impact of brain tumor related epilepsy on the patient’s life;
- Developing and evaluating palliative care programs throughout the disease course, including advance care planning.